What is a partial agonist?

What is a partial agonist?

• A. A molecule that blocks receptor activation
• B. A molecule that increases a neurotransmitter action
• C. A molecule that mimics the transmitter but produces a weaker response
• D. A molecule that causes receptor downregulation

Answer: (C)

A partial agonist binds to a receptor and activates it, but its maximal effect is less than that produced by a full agonist. This means you still get receptor signaling, just not to the full extent, even if the receptor is fully occupied. Because its efficacy is intermediate, a partial agonist can temper the overall response and, in the presence of a full agonist, compete for receptor sites and dampen the effect. That interplay is why partial agonists can act as functional antagonists in some situations. For context, the idea contrasts with a molecule that blocks receptor activation (an antagonist), which produces no activation. Another option describes increasing neurotransmitter action, which would be a full agonist or another mechanism that enhances signaling. Finally, receptor downregulation refers to a longer-term change in receptor numbers rather than the immediate signaling strength of a ligand. A classic example is buprenorphine, a partial agonist at the mu opioid receptor, providing analgesia with a ceiling effect and a safer profile in dependence treatment.

A partial agonist binds to a receptor and activates it, but its maximal effect is less than that produced by a full agonist. This means you still get receptor signaling, just not to the full extent, even if the receptor is fully occupied. Because its efficacy is intermediate, a partial agonist can temper the overall response and, in the presence of a full agonist, compete for receptor sites and dampen the effect. That interplay is why partial agonists can act as functional antagonists in some situations.

For context, the idea contrasts with a molecule that blocks receptor activation (an antagonist), which produces no activation. Another option describes increasing neurotransmitter action, which would be a full agonist or another mechanism that enhances signaling. Finally, receptor downregulation refers to a longer-term change in receptor numbers rather than the immediate signaling strength of a ligand. A classic example is buprenorphine, a partial agonist at the mu opioid receptor, providing analgesia with a ceiling effect and a safer profile in dependence treatment.